The NF-κB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes

Adcock, 2007, Resolution of inflammatory responses: a brief introduction, Biochem Soc Trans, 35, 261, 10.1042/BST0350261 Ashburner, 2001, The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression, Mol Cell Biol, 21, 7065, 10.1128/MCB.21.20.7065-7077.2001 Bondeson, 2000, Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent, J Rheumatol, 27, 2078 Cao, 2006, NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages, J Biol Chem, 281, 26041, 10.1074/jbc.M602222200 Chen, 2003, The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia–reperfusion, Nat Med, 9, 575, 10.1038/nm849 de Ruijter, 2003, Histone deacetylases (HDACs): characterization of the classical HDAC family, Biochem J, 370, 737, 10.1042/bj20021321 Dennis, 2008, The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium, Infect Immun, 76, 4978, 10.1128/IAI.00736-08 Friedman, 2008, Hepatic fibrosis – overview, Toxicology, 254, 120, 10.1016/j.tox.2008.06.013 Friedman, 2008, Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver, Physiol Rev, 88, 125, 10.1152/physrev.00013.2007 Ghosh, 2002, Missing pieces in the NF-kappaB puzzle, Cell, 109, S81, 10.1016/S0092-8674(02)00703-1 Gomez, 2005, Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts, J Immunol, 175, 6924, 10.4049/jimmunol.175.10.6924 Hayden, 2008, Shared principles in NF-kappaB signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020 Hayden, 2004, Signaling to NF-kappaB, Genes Dev, 18, 2195, 10.1101/gad.1228704 Ishikawa, 1998, Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50, J Exp Med, 187, 985, 10.1084/jem.187.7.985 Karin, 2004, The IKK NF-kappa B system: a treasure trove for drug development, Nat Rev Drug Discov, 3, 17, 10.1038/nrd1279 Lawrence, 2007, Chronic inflammation: a failure of resolution?, Int J Exp Pathol, 88, 85, 10.1111/j.1365-2613.2006.00507.x Liacini, 2003, Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes, Exp Cell Res, 288, 208, 10.1016/S0014-4827(03)00180-0 Mann, 2010, MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis, Gastroenterology, 138, 705, 10.1053/j.gastro.2009.10.002 Mann, 2002, CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, and CBF1, J Biol Chem, 277, 17125, 10.1074/jbc.M109250200 Mengshol, 2001, IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways, Nucleic Acids Res, 29, 4361, 10.1093/nar/29.21.4361 Mengshol, 2000, Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3, Arthritis Rheum, 43, 801, 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4 Mizgerd, 2003, Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia, Am J Respir Crit Care Med, 168, 810, 10.1164/rccm.200303-412OC Mizgerd, 2004, NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation, BMC Immunol, 5, 10, 10.1186/1471-2172-5-10 Oakley, 2005, Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury, Am J Pathol, 166, 695, 10.1016/S0002-9440(10)62291-2 Oakley, 2003, Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1, J Biol Chem, 278, 24359, 10.1074/jbc.M211051200 Panzer, 2009, Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases, Am J Physiol, 297, F429 Pereira, 2008, Nuclear factor-kappaB1: regulation and function, Int J Biochem Cell Biol, 40, 1425, 10.1016/j.biocel.2007.05.004 Perkins, 2007, Integrating cell-signalling pathways with NF-kappaB and IKK function, Nat Rev, 8, 49, 10.1038/nrm2083 Porta, 2009, Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB, Proc Natl Acad Sci USA, 106, 14978, 10.1073/pnas.0809784106 Rodriguez, 1999, Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation, J Biol Chem, 274, 9108, 10.1074/jbc.274.13.9108 Saccani, 2006, P50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance, Cancer Res, 66, 11432, 10.1158/0008-5472.CAN-06-1867 Sengchanthalangsy, 1999, Characterization of the dimer interface of transcription factor NFkappaB p50 homodimer, J Mol Biol, 289, 1029, 10.1006/jmbi.1999.2823 Serhan, 2007, Resolution of inflammation: state of the art, definitions and terms, FASEB J, 21, 325, 10.1096/fj.06-7227rev Sheppard, 1999, Transcriptional activation by NF-kappaB requires multiple coactivators, Mol Cell Biol, 19, 6367, 10.1128/MCB.19.9.6367 Strieter, 2008, What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis, Proc Am Thorac Soc, 5, 305, 10.1513/pats.200710-160DR Uchinami, 2006, Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis, Hepatology, 44, 420, 10.1002/hep.21268 Vinas, 2003, Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation, Hepatology, 38, 919, 10.1002/hep.1840380418 Williams, 2006, NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation, EMBO J, 25, 139, 10.1038/sj.emboj.7600900 Winau, 2007, Ito cells are liver-resident antigen-presenting cells for activating T cell responses, Immunity, 26, 117, 10.1016/j.immuni.2006.11.011 Xu, 2005, Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, Gut, 54, 142, 10.1136/gut.2004.042127 Yu, 2009, The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target, Curr Cancer Drug Targets, 9, 566, 10.2174/156800909788486759 Zhong, 2002, The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1, Mol Cell, 9, 625, 10.1016/S1097-2765(02)00477-X Ziegler-Heitbrock, 2001, The p50-homodimer mechanism in tolerance to LPS, J Endotoxin Res, 7, 219, 10.1177/09680519010070030401